References
- Shaikh ZS, Krueper S, Malins TJ. Serotonin syndrome: take a closer look at the unwell surgical patient. Ann R Coll Surg Engl 2011; 93: 569–572.
- Gelener P, Gorgulu U, Kutlu G, Ucler S, Inan LE. Serotonin syndrome due to duloxetine. Clin Neuropharmacol 2011; 34:127–128.
- Rastogi R, Swarm RA, Patel TA. Case scenario: opioid association with serotonin syndrome: implications. Anesthesiology 2011; 115:1291–1298.
- Guo SL, Wu TJ, Liu CC, Ng CC, Chien CC, Sun HL. Meperidine-induced serotonin syndrome in a susceptible patient. Br J Anaesth 2009; 103:369–370.
- Grün B, Merkel U, Riedel K-D, Weiss J, Mikus G. Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine. Br J Clin Pharmacol 2012; 74:854–863.
- Brown TM, Skop BP, Mareth TR. Pathophysiology and management of the serotonin syndrome. Ann Pharmacother 1996; 30:527–533.
- Al-Edrus SA, Norzaini R, Chua R, Puvanarajah S, Shuguna M, Muda S. Reversible splenial lesion syndrome in neuroleptic malignant syndrome. Biomed Imaging Interv J 2009; 5:e24.